Novartis Venture Fund
Overview
Looks for unmet need and clinical impact, novel proprietary science and understanding of mechanism, management and board experience and capital efficiency in the program.
Investment Focus
- Innovative therapeutics and platforms addressing unmet patient needs
- Early-stage life sciences companies
- Global focus with emphasis on North America and Europe
- Active collaboration with portfolio companies to deliver clinical impact
- Companies developing novel therapeutics and platforms
- Early to mid-stage life sciences companies
- Global presence with a focus on North America and Europe
- Active involvement in company boards
- Alignment with Novartis' therapeutic areas including oncology, immunology, neuroscience, and cardiovascular medicine
Portfolio Companies
Get the full list of 54,000+ investors
Novartis Venture Fund and every other firm and angel in the database — as one spreadsheet you keep.
$19one-time payment · no subscription- All 54,000+ investors — VC firms, private equity, family offices and angels
- The key person to contact at each one, with their job title
- Their work email address
- Their phone number
- Their LinkedIn profile
- Delivered as a single .xlsx file — download it as many times as you like
Every profile on this site is one row of the file, with the contact details masked — browse a few before you buy.
Frequently asked questions about Novartis Venture Fund
What sectors does Novartis Venture Fund invest in?
Novartis Venture Fund invests in Healthcare, Life Sciences, Healthcare Services, Digital Health, Pharmaceuticals and Medical Devices, and is based in Massachusetts, United States. Novartis Venture Fund is listed as a vc in the ConnectSafely investor database.
What stage does Novartis Venture Fund invest at?
Novartis Venture Fund backs companies at Seed, Series A, Series B, Growth, Late Stage and Pre-IPO, writing cheques of 5M - 25M.
Which regions does Novartis Venture Fund invest in?
Novartis Venture Fund invests across United States, United Kingdom, Canada, Germany, Japan and China.
What companies has Novartis Venture Fund invested in?
Novartis Venture Fund's portfolio includes Molecular Partners, Alnylam Pharmaceuticals, Chinook Therapeutics, Adimab, Arctos Medical, Cadent Therapeutics, Gyroscope Therapeutics and Kymab.
How do I contact Novartis Venture Fund?
Novartis Venture Fund's contact details — including phone and LinkedIn — are listed in the ConnectSafely investor database, along with its website and the LinkedIn profiles of the team.
Last updated · Source: ConnectSafely investor database
